A detailed history of Geode Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Geode Capital Management, LLC holds 17,005,148 shares of LLY stock, worth $13.6 Billion. This represents 1.37% of its overall portfolio holdings.

Number of Shares
17,005,148
Previous 16,575,196 2.59%
Holding current value
$13.6 Billion
Previous $12.9 Billion 19.4%
% of portfolio
1.37%
Previous 1.21%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$724.87 - $909.04 $312 Million - $391 Million
429,952 Added 2.59%
17,005,148 $15.4 Billion
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $367 Million - $491 Million
619,557 Added 3.88%
16,575,196 $12.9 Billion
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $127 Million - $149 Million
241,414 Added 1.54%
15,955,639 $9.3 Billion
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $221 Million - $305 Million
508,724 Added 3.35%
15,714,225 $8.44 Billion
Q2 2023

Aug 11, 2023

BUY
$350.74 - $468.98 $119 Million - $159 Million
338,077 Added 2.27%
15,205,501 $7.13 Billion
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $49.7 Million - $58.4 Million
159,964 Added 1.09%
14,867,424 $5.11 Billion
Q4 2022

Feb 13, 2023

SELL
$321.55 - $374.67 $445 Million - $518 Million
-1,383,789 Reduced 8.6%
14,707,460 $5.37 Billion
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $111 Million - $126 Million
373,938 Added 2.38%
16,091,249 $5.2 Billion
Q2 2022

Aug 12, 2022

BUY
$278.73 - $327.27 $113 Million - $133 Million
405,075 Added 2.65%
15,717,311 $5.09 Billion
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $136 Million - $169 Million
581,068 Added 3.94%
15,312,236 $4.37 Billion
Q4 2021

Feb 11, 2022

BUY
$224.85 - $279.04 $92 Million - $114 Million
409,009 Added 2.86%
14,731,168 $4.06 Billion
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $79.3 Million - $97.6 Million
357,886 Added 2.56%
14,322,159 $3.3 Billion
Q2 2021

Aug 13, 2021

BUY
$180.55 - $233.54 $102 Million - $132 Million
564,757 Added 4.21%
13,964,273 $3.2 Billion
Q1 2021

May 12, 2021

BUY
$164.32 - $212.72 $36.3 Million - $47 Million
221,092 Added 1.68%
13,399,516 $2.5 Billion
Q4 2020

Feb 12, 2021

BUY
$130.46 - $172.63 $158 Million - $210 Million
1,214,688 Added 10.15%
13,178,424 $2.22 Billion
Q3 2020

Nov 13, 2020

SELL
$146.22 - $169.13 $94.8 Million - $110 Million
-648,327 Reduced 5.14%
11,963,736 $1.77 Billion
Q2 2020

Aug 13, 2020

SELL
$136.42 - $164.18 $4.86 Million - $5.84 Million
-35,594 Reduced 0.28%
12,612,063 $2.07 Billion
Q1 2020

May 14, 2020

BUY
$119.05 - $147.35 $32.2 Million - $39.9 Million
270,650 Added 2.19%
12,647,657 $1.75 Billion
Q4 2019

Feb 13, 2020

BUY
$106.92 - $132.43 $24.2 Million - $30 Million
226,620 Added 1.87%
12,377,007 $1.62 Billion
Q3 2019

Nov 12, 2019

SELL
$106.79 - $116.16 $42.5 Million - $46.2 Million
-397,850 Reduced 3.17%
12,150,387 $1.36 Billion
Q2 2019

Aug 14, 2019

BUY
$110.79 - $129.32 $30.7 Million - $35.8 Million
276,741 Added 2.26%
12,548,237 $1.39 Billion
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $93.1 Million - $110 Million
-836,506 Reduced 6.38%
12,271,496 $1.59 Billion
Q4 2018

Feb 13, 2019

BUY
$105.9 - $118.64 $88 Million - $98.6 Million
830,689 Added 6.77%
13,108,002 $1.51 Billion
Q3 2018

Nov 13, 2018

BUY
$85.86 - $107.31 $47 Million - $58.8 Million
547,633 Added 4.67%
12,277,313 $1.32 Billion
Q2 2018

Aug 14, 2018

BUY
$75.7 - $86.88 $93.1 Million - $107 Million
1,229,984 Added 11.71%
11,729,680 $999 Million
Q1 2018

May 15, 2018

BUY
$74.21 - $87.6 $47.8 Million - $56.5 Million
644,732 Added 6.54%
10,499,696 $810 Million
Q4 2017

Feb 13, 2018

BUY
$81.94 - $87.89 $33.3 Million - $35.8 Million
406,812 Added 4.31%
9,854,964 $831 Million
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $16.2 Million - $18 Million
210,087 Added 2.27%
9,448,152 $807 Million
Q2 2017

Aug 14, 2017

BUY
N/A
9,238,065
9,238,065 $759 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $758B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.